panaxadiol has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, L; Liang, X; Lin, Y; Shi, Y; Xiao, H; Yang, J; Yao, Y | 1 |
| Chong, BH; Gao, R; Jiang, X; Lin, X; Liu, Q; Xu, W; Yin, L | 1 |
| Chen, Y; Du, Y; Fang, Y; Gao, P; Li, Y; Meng, Y; Wang, X; Yang, G; Zhao, X | 1 |
3 other study(ies) available for panaxadiol and Disease Models, Animal
| Article | Year |
|---|---|
Panaxadiol inhibits synaptic dysfunction in Alzheimer's disease and targets the Fyn protein in APP/PS1 mice and APP-SH-SY5Y cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Line; Disease Models, Animal; Ginsenosides; Humans; Memory; Memory Disorders; Mice; Mice, Transgenic; Phosphorylation; Proteins; Proto-Oncogene Proteins c-fyn; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synapses | 2019 |
The effects of panaxadiol saponins on megakaryocytic maturation and immune function in a mouse model of immune thrombocytopenia.
Topics: Animals; Cell Differentiation; Disease Models, Animal; Dose-Response Relationship, Drug; Erythrocytes; Female; Ginsenosides; Humans; Macrophages; Male; Megakaryocytes; Mice, Inbred BALB C; Phagocytosis; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Saponins; Time Factors | 2015 |
Panaxadiol Saponin and Dexamethasone Improve Renal Function in Lipopolysaccharide-Induced Mouse Model of Acute Kidney Injury.
Topics: Acute Kidney Injury; Animals; Dexamethasone; Disease Models, Animal; Ginsenosides; Kidney; Lipopolysaccharides; Malondialdehyde; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type II; Receptors, Glucocorticoid; Superoxide Dismutase | 2015 |